Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04782284

Comprehensive Swallowing Rehabilitation in Patients With MSA

Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy.

Detailed description

Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease characterized by parkinsonism, cerebellar syndrome, and autonomic failure. Dysphagia is a clinically significant symptom leading to pneumonia that causes death in patients with MSA. Although the symptoms of dysphagia in the two subtypes of MSA-the parkinsonian variant and the cerebellar variant- are different, there is no significant difference in the latency to onset of tube feeding. Therefore, effective intervention is needed to improve the safety and efficiency of swallowing regardless of the subtypes of MSA. Although swallowing rehabilitation has been widely applied for swallowing disorders in patients with MSA, few studies have reported the clinical effect of applying swallowing therapy. Comprehensive swallowing rehabilitation has focused on functional muscle training, compensatory swallowing maneuvers, and thermal-tactile stimulation, which is used to treat dysphagia from stroke, Parkinson's disease, and head and neck cancer. Therefore, this study aims to investigate the effect of comprehensive swallowing rehabilitation in patients with MSA.

Conditions

Interventions

TypeNameDescription
OTHERComprehensive swallowing rehabilitationThe treatment time per session is 30 minutes. Total 12 sessions are provided for 6 weeks.
OTHERSwallowing educationThe education is 30 minutes. Total 1 session is provided immediately after baseline evaluation.

Timeline

Start date
2021-05-17
Primary completion
2025-10-31
Completion
2025-12-31
First posted
2021-03-04
Last updated
2025-05-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04782284. Inclusion in this directory is not an endorsement.